BASF, Essentium and Materialise Partner to Accelerate Industrial Additive Manufacturing

Share this Article

For more than a year, BASF and Essentium have been working together to develop advanced 3D printing materials with high mechanical strength, using Essentium’s proprietary FlashFuse technology. The two companies are now extending their strategic partnership to establish a consistent global materials supply chain that supports Essentium’s new High Speed Extrusion (HSE) 3D printing platform. Materialise will also be joining them to develop 3D printing software for Essentium’s technology. Users will be able to take advantage of the speed of HSE technology while having immediate access to Materialise’s full professional 3D printing software capabilities.

“Materialise, Essentium and BASF share a vision for growth in the 3D printing industry that builds on the creation of meaningful applications in an open and vibrant ecosystem,” said Bart Van der Schueren, CTO of Materialise. “This partnership helps to promote a more open market model, which will fuel the adoption of 3D printing in the industrial field by offering users more control, more choice in materials and ultimately lower cost and higher volumes.”

The partnership will benefit from BASF’s material expertise as well as its large product portfolio and global network. Materialise brings its comprehensive software knowledge, while Essentium adds its developing 3D printing platform, which includes its FlashFuse technology and engineering-grade, multi-layer filaments.

“Our joint investment strengthens our co-operations with both Essentium and Materialise and accelerates the innovation potential of this powerful team to the benefit of BASF’s customers,” said Markus Solibieda, Managing Director of BASF Venture Capital.

This robotic soft-touch gripper has been made with highly flexible Ultrafuse filaments using Essentium’s HSE technology.

BASF Venture Capital is leading the Series A investment round in Essentium, joined by Materialise as well as a syndicate of private venture investors.

“With this strategic investment, Essentium and BASF are focusing on improved supply chain performance, material consistency and accessibility,” said Dr. Blake Teipel, CEO of Essentium. “Essentium is also delighted to begin a new partnership with Materialise as the three companies focus efforts toward a new era for smart solutions in the global additive extrusion space. Together, we believe manufacturers everywhere will be able to accelerate production due to increased access to our new solutions, bolstered by a holistic, customer-centric approach.”

BASF, Materialise and Essentium state that they are aiming to drive the transition from 3D printing to additive manufacturing – but what does this really mean? Overall, their vision is to take 3D printing from a prototyping to a true manufacturing technology, firmly establishing a place for it on the production floor. The three companies in the new partnership plan to bring their respective strengths in hardware, software and materials together to do so. Higher speeds, stronger materials and more comprehensive software are all parts of the plan to make additive manufacturing a technology that can truly compete with other manufacturing methods in both large and small scale production settings.

Discuss this and other 3D printing topics at 3DPrintBoard.com or share your thoughts below. 

 

 

Share this Article


Recent News

London: 3D Printing the Double-Ridged Horn Antenna for Biomedical Monitoring

Bioprinting Hot Dogs with Hierarchical Structures



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

China: Improving Cell Viability by Refining Structural Design in Scaffolds

Chinese researchers are seeking new ways to create stronger cell growth and sustainability in scaffolds. With their findings outlined in the recently published, ‘Structure-induced cell growth by 3D printing of...

Interview with Johnson & Johnson’s Bioprinting Lead Orchid Garcia

Orchid Garcia is a Research Fellow and Lead for 3D Bioprinting and Tissue Regen Technologies at Johnson & Johnson. As Johnson & Johnson’s technical lead for bioprinting she is both...

Digilab: On the State of Bioprinting Today

In a recent interview with Digilab‘s CEO Sidney Braginsky, Senior Applications Manager Igor Zlatkin, and John Moore, President and COO, 3DPrint.com got a glimpse of the focus, future, and advances...

Vienna: 3D printing Prototypes for Cutting the Cost of Lab-on-a-Chip & Organ-on-a-Chip Systems

A variety of new microfabrication methods are available now for creating rapid prototypes and new systems, and Vienna University of Technology researchers explain new research in ‘Characterization of four functional...


Shop

View our broad assortment of in house and third party products.


Print Services

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our 3DPrint.com.

You have Successfully Subscribed!